Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
BioInformatics, LLC New Report - New Media Marketing Channels: Creating Effective Online Life Science Promotional Videos
The NIAID-Supported Pathogen Functional Genomics Resource Center at the J. Craig Venter Institute Offers New Affymetrix Array for Faster Identification of E. Coli and Shigella
Affymetrix Reports Second Quarter 2009 Results
Affymetrix Reports Second Quarter 2009 Results ; -- Company Reports Total Revenue of $81.6 Million and Net Income of $7.3 Million --
Affymetrix to Host Conference Call on July 22, 2009 to Announce Second Quarter 2009 Results
Affymetrix to Webcast Annual Meeting of Shareholders
Key Milestones to Improve Operating Leverage Achieved Ahead of Schedule
Affymetrix, Inc. (AFFX) President and Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell
Affymetrix Chief Medical Officer to speak at AAAS on Personalized Medicine
Entrepreneur Magazine Picks Affymetrix as One of Top 100 Companies to Watch
Affymetrix to Webcast Investor Day 2009
Affymetrix Appoints Gary Guthart to Board of Directors
Affymetrix to Webcast Presentations at May Financial Conferences
Affymetrix Chosen as One of the Top Places to Work in the Bay Area
Six New Genes Associated with Heart Attacks
Affymetrix to Host Conference Call on April 22, 2009 to Announce First Quarter 2009 Results
WallStSense.Com Free Research Report for Shareholders of ILMN, FLIR, TRMB and AFFX
New Cytogenetics Products Offer Best Overall Approach for Detection of Chromosome Aberrations
Affymetrix and Genisphere Launch Best-in-Class Solution for microRNA Expression Research - Mar 16 2009 11:56PM
Affymetrix and Genisphere Launch Best-in-Class Solution for microRNA Expression Research - Mar 16 2009 8:27AM
New Report - Prospering in a Down Market: Strategies for Life Science Suppliers
Affymetrix to Webcast Presentations at Two March Financial Conferences
Affymetrix Reports Fourth Quarter and Fiscal Year 2008 Results
Affymetrix to Host Conference Call on January 28, 2009 to Announce Fourth Quarter and Fiscal 2008 Results
Coriell Institute for Medical Research Selects Affymetrix DMET Plus Product for National Personalized Medicine Project
Affymetrix to Webcast Presentation at JPMorgan Healthcare Conference
Affymetrix Technology Powers Cincinnati Children’s Hospital’s Innovative Test for Jaundice
Affymetrix Completes Acquisition of Panomics
Researchers Use Affymetrix Technology to Discover Why Some Breast Cancer Patients Resist Tamoxifen
Affymetrix to Webcast Presentation at Piper Jaffray Healthcare Conference
HTG Names Fredrick Pollock VP of Corporate Development
Affymetrix to Acquire Panomics
Affymetrix Announces New Cost-effective Product for Standardizing Drug Metabolism Studies
Affymetrix Reports Third Quarter 2008 Results
Zacks Earnings Preview: Deckers Outdoor, JetBlue Airways, Timken and Affymetrix
Affymetrix Appoints Rick Runkel to Executive Vice President and General Counsel
BellwetherReport.Com Analyst Opinions on DISH, AFFX, CNQR and ESRX
Affymetrix Announces Preliminary Third Quarter Revenue
South African Core Lab Adopts Affymetrix Technology for Genomic Studies
Wall Street Journal Selects PhyloChip Developed on the Affymetrix Platform as a Top Technology Innovation
Affymetrix and Medical Prognosis Institute Collaborate to Develop Cancer Treatment Products
Affymetrix' GeneTitan(TM) System Delivers Automatic Answers and Sets New Standard in Genomic Analysis
Wellcome Trust Sanger Institute Uses Affymetrix Technology to Reveal Changes in 800 Cancer Cell Lines
Affymetrix to Webcast Presentation at UBS Global Life Sciences Conference
Affymetrix Launches 3' IVT Express Kit for Faster, More Reliable Target Preparation
Affymetrix to Webcast Presentations at Two September Financial Conferences
Affymetrix Technology Helps Advance Schizophrenia Research
Affymetrix to Webcast Presentation at Leerink Swann Life Sciences Tools Conference
Affymetrix Microarray Platform Granted Clearance from FDA for Gene Expression Diagnostic Testing
BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX
Wellcome Trust Case Control Consortium and Affymetrix Expand World's Largest Study of Genetic Diseases
Affymetrix Reports Second Quarter 2008 Results
Affymetrix to Host Conference Call on July 24, 2008 to Announce Second Quarter 2008 Results
Affymetrix Technology Used to Discover Molecular Mechanisms of Liver Disease
Center for Inherited Disease Research Adds Affymetrix Platform for Large-Scale Genotyping Services
Case Western Reserve University and TGen Select Affymetrix SNP Array 6.0 for Diabetes Study
Affymetrix Technology Powers First Genomic Tumor Grading Test for Breast Cancer
Affymetrix Applauds Congress and President for Enacting the Genetic Information Nondiscrimination Act - May 27 2008 1:34AM
Korea NIH Expands KARE Project with Second Affymetrix Technology Order - Jun 1 2008 6:49AM
LineaGen Selects Affymetrix Technology to Discover Genes Associated With Autism and Multiple Sclerosis - Jun 1 2008 6:49AM
Affymetrix to Webcast Presentations at May Financial Conferences
Affymetrix Reports First Quarter 2008 Results
Affymetrix Technology Powers Innovative Pathwork(R) Diagnostics, Inc. Cancer Test
BellwetherReport.com Initiates Analyst Coverage on CROX, AFFX, NVTL and CPWR
Affymetrix Extends Collaborations in Cancer Research Program to North America
AltheaDx Named Affymetrix Authorized Service Provider
Affymetrix Announces Preliminary First Quarter Revenue
Epigenomics AG: PITX2 Prostate Cancer Molecular Classification Test Successfully Transferred to Affymetrix Diagnostic Platform
Keller Rohrback Announces Derivative Lawsuit Filed Against Affymetrix, Inc. -- AFFX
Genpathway Signs Worldwide Agreement With Affymetrix to Provide ChIP-on-Chip Assay Services for New GeneChip(R) Tiling Array Systems
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia